| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Halozyme Therapeutics, Inc. (HALO) has 10 insiders with recent SEC Form 4 filings, including 3 buys and 24 sells. HALO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 777.8K | $53.66M | - | |
| Dir | 77.8K | $5.37M | - | |
| Dir | 43.7K | $3.01M | -1,625 | |
| Dir | 36.6K | $2.52M | - | |
| Dir | 23.7K | $1.64M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2020 | Matsui Connie | Director | Sell | 32,000 | $27.06 | $865,792.00 | -12.9% | |
| Aug 20, 2020 | Labarre Michael J.52 | SVP, Chief Technical Officer | Sell | 12,000 | $28.30 | $339,564.00 | -6.6% | |
| Aug 13, 2020 | Daly James M | Director | Sell | 34,337 | $29.12 | $999,893.44 | -52.3% | |
| Jul 20, 2020 | Labarre Michael J.52 | SVP, Chief Technical Officer | Sell | 12,000 | $29.01 | $348,072.00 | -6.2% | |
| May 20, 2020 | Labarre Michael J.52 | SVP, Chief Technical Officer | Sale+OE | 21,387 | $23.80 | $509,074.76 | -10.8% | |
| Mar 19, 2020 | Kelley Kenneth J | Director | Buy | 52,629 | $14.23 | $748,696.65 | +7.2% | |
| Aug 3, 2019 | Chondros Dimitrios | SVP, Chief Medical Officer | Sell | 1,328 | $16.70 | $22,177.60 | -3.3% | |
| Aug 28, 2018 | Kirk Randal J | 10% Owner | Sell | 644,998 | $18.08 | $11,663,346.32 | -3.4% | |
| Aug 23, 2018 | Kirk Randal J | 10% Owner | Sell | 1,194,462 | $17.65 | $21,085,138.39 | -5.5% | |
| Aug 16, 2018 | Kirk Randal J | 10% Owner | Sell | 490,072 | $17.30 | $8,476,982.75 | -2.1% |